Metabolic syndrome linked to arterial stiffness in CKD

June 4, 2012
Metabolic syndrome linked to arterial stiffness in CKD

(HealthDay) -- For patients with chronic kidney disease (CKD), those with metabolic syndrome (MetS) have increased arterial stiffness but no increase in endothelial dysfunction, compared to those without MetS, according to a study published online May 29 in Diabetes Care.

Pajaree Lilitkarntakul, M.D., from the University of Edinburgh in the United Kingdom, and colleagues assessed carotid-femoral pulse wave velocity (CF-PWV) and flow-mediated dilation (FMD) as measures of arterial stiffness and endothelial dysfunction, respectively, in 113 minimally comorbid CKD patients and 23 matched controls.

The researchers found that there were significant associations for systolic blood pressure (SBP), waist circumference, and with CF-PWV (r², 0.25, 0.09, and 0.09, respectively). FMD was significantly associated with both SBP and waist circumference (r², 0.09 and 0.03, respectively). As the number of risk factors for MetS increased, CF-PWV increased progressively (r² = 0.07). Independent determinants for CF-PWV were SBP and , but only SBP predicted FMD.

"CKD patients with MetS have increased arterial stiffness compared with those without MetS but no difference in endothelial function," the authors write. "Although blood pressure remains the strongest determinant of both arterial stiffness and , the presence of MetS or its risk factors is also an important determinant of arterial stiffness in this CKD cohort."

Explore further: A novel method for simultaneously measuring blood pressure and arterial stiffness

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Low-carb diet may aid your metabolism

December 2, 2016

(HealthDay)—Eating low-carbohydrate meals may lead to healthy changes in a woman's metabolism that don't occur when consuming higher-carbohydrate meals, a small study suggests.

Research shows nerve growth protein controls blood sugar

November 14, 2016

Research led by a Johns Hopkins University biologist demonstrates the workings of a biochemical pathway that helps control glucose in the bloodstream, a development that could potentially lead to treatments for diabetes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.